A Field Guide to Female Fertility

Pre-conception planning is not a checklist and it is not a test you pass. It is a systems read on the internal and external conditions that decide whether a pregnancy can initiate, sustain, and develop well. The menstrual cycle is the primary data source, the hormones are the readout, and the metabolic, immune, and environmental context is the ground everything stands on. Most of what shows up in a pre-conception workup is not catastrophic pathology - it is a collection of individually minor, collectively decisive readings that quietly explain why nothing has happened yet.

This guide is female-focused by design - the architecture below is specific to female reproductive physiology. But male factor accounts for roughly 40-50% of infertility, and it is routinely diagnosed late because the assumption is that the female workup is the one that needs running. A semen analysis is a short investment that shifts the whole diagnostic frame if it comes back abnormal. Both partners get the workup. Both partners get the environmental and nutritional work.

Before you begin

Is this for you?

This guide is for

Women actively trying to conceive or planning to within the next one to three years
Women with unexplained cycle irregularity, recurrent miscarriage, or a diagnosis of PCOS, endometriosis, or diminished ovarian reserve
Women who want to understand their own reproductive physiology well enough to ask better questions and make better decisions - whether or not a pregnancy is imminent
Couples who want to address the foundation before conception - metabolic, environmental, and nutritional - rather than reactively after

This guide is not for

Anyone who needs an IVF, ovulation-induction, or fertility-treatment program - this builds the biological conditions for fertility; it is not a clinical treatment protocol
Women who are already pregnant - several items here (melatonin, DHEA, some botanicals) are pre-conception only and are not for use once trying to conceive or pregnant without provider oversight
Anyone wanting a diagnosis or a prescription by mail - the labs and protocol here are built to be brought to a clinician, not to replace one

This is not a substitute for a clinical relationship. It describes mechanisms, flags the levers that matter most, and tells you what to track. Agency stays with you - and the whole picture still benefits from a clinical eye looking at the system rather than ordering the standard panel and waiting for something to fall out of range.

The mechanism

A system, not a switch

The reproductive story starts before you were born. By the end of fetal development your ovaries are already stocked with essentially all the follicles you will ever have - on the order of a few million oocytes generated in utero, declining from there. There is emerging research on ovarian stem cells and intra-ovarian PRP (platelet-rich plasma) as stimulants for new follicle generation, but any contribution appears minimal by comparison and is not established practice. Stated plainly: the eggs you are working with now were made while your mother was pregnant with you. That framing matters for pre-conception planning - it is not only your pregnancy, it is the developmental environment the next generation will sit inside.

The working system is the hypothalamic-pituitary-ovarian (HPO) axis. The hypothalamus releases GnRH (gonadotropin-releasing hormone) in pulses; the pituitary answers with FSH and LH (follicle-stimulating and luteinizing hormone); those gonadotropins drive the ovary to mature follicles and produce estradiol and progesterone; and the ovarian hormones feed back to restrain the pulse. A break anywhere along that chain shows up as an irregular or absent cycle - and where it breaks decides what actually helps.

An irregular or absent cycle can come from a break at any level of this chain. Which level is what the cycle pattern and the hormone panel read out - and it decides whether the fix is metabolic, hypothalamic, or ovarian.

The axis first switches on at thelarche - the start of breast development, reflecting the first meaningful estrogen production - with menarche and then reliable ovulation following over the next two to three years on average. That onset is tightly regulated by body-fat stores and leptin, which is why both extremes of body composition, too lean and too heavy, can distort the timing and coordination of reproductive function. That sensitivity to energy availability never goes away - it is the same signal the system reads before every cycle.

The primary data source

Reading the cycle

If conception is the goal, the menstrual cycle is not background noise - it is the primary data source. There are four phases, each with a distinct hormonal signature and each capable of going wrong in ways that accumulate downstream.

The follicular phase. As the previous luteal phase ends, circulating hormones drop and release the brake on gonadotropin release. FSH and LH rise, the endometrium loses its growth signal and sloughs - that is menses, which should run about three to five days with the heaviest flow in the first half. By roughly day seven, FSH and local growth factors have recruited a cohort of follicles to compete, and this is where AMH (anti-Mullerian hormone) is produced, making it the primary marker of ovarian reserve. As the dominant follicle grows, its estradiol and inhibin B rise and suppress FSH - so only follicles that no longer need FSH support survive the cut, and the rest atrophy. Estradiol then peaks, the brake lifts, the LH surge fires, and ovulation is triggered.

Extended or very heavy menses - say five to six days of heavy bleeding followed by days of spotting - is common, but it is not what the cycle is built to do. A dragged-out follicular phase can mean oocyte recruitment and maturation do not finish before ovulation is due, which can show up downstream as luteal phase deficiency or anovulation. Different patterns can emerge from the same root kink in the chain.

Ovulation and the luteal phase. The LH surge tells the chosen oocyte to resume division, detach from the follicular scaffolding, and rupture the follicle wall; it then travels down the fallopian tube. The ruptured follicle becomes the corpus luteum, which secretes progesterone to shift the uterine lining into its secretory, implantation-ready state. If the follicle was not large enough at rupture, or the corpus luteum cannot sustain progesterone, implantation and early pregnancy maintenance become difficult. If an embryo implants, it secretes hCG (human chorionic gonadotropin), which keeps the corpus luteum producing progesterone through early pregnancy - and that hCG is what a pregnancy test detects.

The fertile window opens several days before ovulation and closes just after it. A urine LH strip predicts ovulation by catching the pre-ovulatory surge - it cannot confirm release happened. The one test that confirms ovulation is a mid-luteal serum progesterone.

Predict is not confirm. Urine LH strips, basal body temperature, and cervical-mucus changes help you time intercourse, but none of them prove an egg was released. LH strips detect the surge that precedes ovulation; a temperature shift and secretory-phase signs come after it but are indirect. To actually confirm ovulation occurred in a given cycle, the test is a mid-luteal serum progesterone (drawn about seven days after suspected ovulation, often day 19-21) showing the expected rise. This distinction matters most in cycles that look regular on the surface but are not releasing an egg.

A note on NSAIDs around ovulation. NSAIDs - ibuprofen, naproxen, aspirin at therapeutic doses - inhibit cyclooxygenase (COX), and COX-driven prostaglandin signaling is part of what ruptures the follicle. Chronic or high-dose NSAID use in the days around ovulation can blunt or delay rupture, occasionally producing a luteinized unruptured follicle - where the LH surge fires and the corpus luteum forms but the oocyte never releases. This is reversible on discontinuation and is an under-appreciated cause of cycle-to-cycle difficulty in women who reach for NSAIDs habitually. Acetaminophen does not share this mechanism and is the cleaner choice when something is needed.

The oocyte

Egg quality and the age question

Oocytes have been arrested since fetal development and do not fully "work" until they are called up for maturation - so in theory age should not degrade them. In practice it does, and the proposed mechanisms are disrupted DNA-repair machinery, dysfunction in chromatid cohesion, and accumulated environmental and physiologic insults to the cell over time. That is compounded by age-related change across the whole system - hormonal regulation, uterine responsivity, fallopian-tube cilia function, systemic inflammation, structural integrity. The oocyte does not age in isolation; the environment it matures in ages with it.

The practical point is that egg quality is not fixed at any given age - several of its inputs are modifiable, and the maturation window that matters is roughly the ninety days before ovulation. That is the window most of the cellular support in this guide is aimed at.

Age and lifetime exposure set a baseline you cannot fully rewind - but mitochondrial function, oxidative balance, and the metabolic environment are inputs you can move in the ninety days before conception, which is why the cellular-support tier exists.

If you want a family but the timing is not right - the partner is not there, the circumstances are not stable - consider banking eggs sooner rather than later. Oocyte quality and quantity both decline with age, and the grief of wanting to reproduce and finding the window has closed is real. An insurance policy that is never claimed is still worth having. This is a conversation to have with a reproductive endocrinologist while the option is widest.

Timing & transition

Tracking, timing, and coming off contraception

All of this architecture serves a narrow fertile window, so timing is the operational front on top of everything else - and the data you bring to it determines how precisely you can work. The general consensus on optimal timing is intercourse every one to two days beginning around day five to seven of the cycle, increasing to daily in the one to two days immediately before ovulation and through ovulation itself. Semen quality - motility, morphology, count - degrades with more than two to three days of abstinence, so more frequent intercourse tends to produce both better sperm quality and better pregnancy rates.

For tracking, a combined read of estradiol, progesterone, LH, and FSH metabolites across the cycle (some at-home systems track all four) tells you more than a single LH strip, because you are watching the whole hormonal arc rather than guessing at one point. Simpler methods each carry a caveat worth stating precisely: basal body temperature (BBT) rises after ovulation because progesterone shifts the hypothalamic temperature setpoint, so it is a post-hoc confirmation of a pattern across cycles, not a way to time a single cycle in real time. Cervical mucus taking on a raw-egg-white consistency is the more actionable acute signal that the fertile window is open. And as above, ovulation-prediction kits predict the surge - they do not confirm release.

Coming off hormonal contraception. A meaningful fraction of women entering pre-conception planning are stopping contraception, and the return-to-cycling profile is not uniform across methods - partly because the methods do not all act the same way. This is worth getting right, because "birth control" is not one thing.

A combined pill suppresses the HPO axis and stops ovulation - its placebo-week bleed is a withdrawal bleed, not a true period. A hormonal IUD acts mainly on the endometrium and a copper IUD is non-hormonal, so both often leave ovulation and hypothalamic signaling intact - with one caveat: the higher-dose 52mg hormonal IUD suppresses ovulation in most cycles during its first year, easing as it ages, so with a recent one, confirm ovulation rather than assume it. Return-to-cycling runs from one to three months for the pill to six to twelve-plus months for the depot injectable, which has no way to be accelerated.

The cycle that returns is not always the cycle that was suppressed. Patterns that pre-dated contraception - PCOS, luteal phase deficiency, an anovulatory tendency - often re-emerge once the exogenous hormone clears, and they get attributed to the contraception when the contraception was actually masking them. Starting the blood work and the supplement foundation before discontinuation, not after, gives you a head start on the picture that is actually underneath.

The foundation

The internal environment

Getting the external architecture right - cycle tracking, timing, supplement protocol - is the operational front. But the internal environment is the ground it sits on, and if that is dysregulated the architecture does not matter much. When the brain assesses whether conditions are suitable for a pregnancy, the primary signals it reads are metabolic and psychoneuroendocrine.

Stress and the psychoneuroendocrine dimension

Rates of depression in women experiencing infertility have been compared to those in serious-illness populations, and it is estimated that roughly one in eight couples have difficulty conceiving or sustaining a pregnancy - most of whom tell no one, which compounds the burden. That burden is also mechanistically consequential. Chronic psychosocial stress elevates cortisol and suppresses the HPO axis through a well-documented pathway - not a speculative one. The organism assesses its own capacity to support a pregnancy, and when it reads the conditions as not-ready, it attenuates the reproductive signal through the same primitive circuit that governs reproductive resource allocation under load. This is physiology, not metaphor - and it is part of why some women conceive naturally after letting go of the pressure that accompanied years of trying.

The internal environment of a pregnancy begins to be written before the pregnancy. Genes tied to stress resilience - cortisol-receptor function, serotonin signaling, neural growth factors - show epigenetic differences in children born to chronically stressed mothers. Addressing the stress axis in the pre-conception window is not a soft variable; it acts on the same wiring the reproductive physiology runs on.

Metabolic function

Leptin and adipokines communicate energy availability and body composition to the hypothalamus, and if that read is "not ready," the HPO axis is muted before anything else can happen. Two systems earn priority. First, blood sugar and insulin: even without obesity, dysregulated insulin and glucose disrupt cycling, ovulation, and oocyte health - PCOS is the clearest example, but metabolic dysfunction is implicated broadly, and if pregnancy occurs against that background, miscarriage, fetal-abnormality, and complication risks rise. The metabolic piece is best addressed before conception, not after. Second, thyroid: the thyroid and sex-hormone systems are interlinked enough to treat together as low-hanging fruit - thyroid hormones affect ovulation timing, implantation, premature-birth risk, and maternal mood, and a full thyroid panel is a non-negotiable part of the workup. The fix is often not thyroid replacement alone; restoring sex-hormone balance and immune function is frequently what lets the hypothalamic-pituitary-thyroid axis self-correct.

Body composition, read as a signal. The literature is consistent: both excess adiposity and being underweight raise infertility rates. This is not about aesthetics or an arbitrary BMI cutoff - it is about what fat mass signals metabolically: inflammation, insulin resistance, altered sex-hormone metabolism, disrupted leptin signaling. The target is lean and fat mass in a range that supports metabolic function, not a number on a scale. Cross-reference the Metabolic Derailment guide if insulin resistance is part of your picture.

Substances that earn their own mention

Cannabis and nicotine warrant separate treatment from the broader lifestyle category because the mechanisms are specific. The endocannabinoid system is directly involved in reproduction - CB1 and CB2 receptors are expressed on oocytes, the endometrium, and sperm - and regular cannabis use is associated with reduced ovulatory frequency, altered luteal characteristics, and lower implantation rates on the female side, with decreased count, motility, and morphology on the male side. Nicotine is well-established as a driver of accelerated ovarian aging - earlier menopause, lower AMH at any given age - and the less-appreciated point is that nicotine itself, independent of combustion, has direct effects on follicular vasculature and oocyte mitochondrial function. Vaping and pouches are not the safer reproductive alternative they are often assumed to be; the exposure is the nicotine, not just the smoke. For both, discontinuation roughly sixty to ninety days before attempting conception aligns with the oocyte and spermatogenesis maturation windows. Neither needs a moral framing to take seriously - the question is only whether the reproductive system is being asked to carry an avoidable load.

Immune tolerance

An embryo is fifty percent genetically foreign, and the mechanism that keeps the maternal immune system from destroying it involves placental barrier function and a deliberate, coordinated dampening of non-self sensitivity. That process is imperfect, which is part of why autoimmune conditions - and even circulating autoantibodies such as antinuclear or antiphospholipid antibodies in the absence of diagnosable disease - can raise miscarriage rates. An often-overlooked observation: longer cohabitation with unprotected sex with the same partner is associated with lower miscarriage and preeclampsia risk, a pattern attributed to developing tolerance to partner-specific antigens. It is not a mainstream conversation, but the association exists and belongs in the clinical picture.

The visceral microbiomes

The gut microbiome does not stay in the gut. A specific bacterial community - the estrobolome - produces beta-glucuronidase, which deconjugates estrogens in the intestinal lumen and sets how much is reabsorbed versus excreted. Dysbiosis there can skew estrogen recirculation toward estrogen excess relative to progesterone, with the clinical picture of heavy periods, worse PMS, and endometriosis or fibroid progression. There is also a distinct uterine microbiome - the endometrium is not sterile - and a Lactobacillus-dominant environment is associated with better implantation and live-birth outcomes in IVF studies, while a non-Lactobacillus-dominant one correlates with implantation failure and recurrent miscarriage. The mechanism is not fully mapped and likely involves local immune tolerance and the cytokine environment at the endometrial surface. This cannot be fixed by gut probiotics alone; the uterine environment has its own composition and its own levers.

Testing exists for the endometrial piece. An endometrial microbiome and infectious-disease assessment (for example the EMMA/ALICE panel) evaluates uterine microbiome composition and the presence of chronic-endometritis pathogens, which show up in a meaningful share of women with unexplained implantation failure and go undetected on standard workup. Practically: support the gut with diverse plant fiber and fermented foods, address known dysbiosis before conception, and consider the endometrial assessment specifically with a history of implantation failure or recurrent miscarriage. It is one of the more actionable and under-used levers in the pre-conception picture.

The load

The external environment

The environment shapes the epigenome - not only of the pregnancy, but of the oocytes that precede it, because the eggs being recruited now have been accumulating environmental insults since before you were born. Pre-conception reduction of that load is a mechanistically coherent intervention, and the highest-leverage moves are unglamorous.

Water

Whole-home filtration

The single highest-leverage investment for those actively preparing for pregnancy. Common pollutants - pesticides, herbicides, pharmaceuticals, heavy metals - enter through what you drink and through skin contact while washing. A whole-house filter addresses both; if that is out of reach, at minimum a counter filter rated for pharmaceuticals, heavy metals, and common chemicals. The skin is the largest interface between you and the outside, so the water you wash with matters as much as the water you drink.

Air

HEPA filtration

Air pollution is chronic and under-addressed in fertility conversations. HEPA filtration in the home and workspace is a low-effort, meaningful reduction in total inhaled particulate and chemical load. The respiratory membranes are a major exchange surface - what gets in through the lungs reaches systemic circulation.

Fragrance

Synthetic fragrances

Perfume, scented candles, plug-in fresheners, scented detergent and dryer sheets, scented personal care. The "fragrance" designation is a labeling loophole that lets manufacturers combine dozens of undisclosed chemicals - frequently including phthalates, documented endocrine disruptors - under one proprietary term. The exposure is daily and enters through inhalation and skin at once. Switching to fragrance-free across personal care, cleaning, and laundry is one of the highest-leverage low-effort moves available.

Receipts

Thermal-paper receipts

The shiny receipts from gas pumps, restaurants, and retail counters are coated with BPA or BPS as the printing substrate. Skin contact transfers a measurable amount, and absorption increases substantially with hand-sanitizer or lotion residue on the skin. Decline the receipt or take the digital version - a daily exposure most people do not know they are having.

The phthalate-fertility association is well-replicated at this point, including cohort data showing dose-dependent relationships between urinary phthalate metabolites and IVF outcomes - one of the cleaner exposure-outcome relationships in the reproductive literature. For those who want an objective read before conceiving, blood and urine xenobiotic testing is available; if the burden is high, supervised strategies - regular sweating through exercise or sauna, targeted nutraceuticals, or medical support - can help clear it before rather than after conception. Any active detoxification effort belongs under provider oversight and is not for use once pregnant.

The protocol

How to supplement

The protocol below is what gets recommended most consistently in active pre-conception planning. It is built around the hormonal, metabolic, and cellular requirements the data best supports - not a comprehensive list of everything with a fertility-related citation attached. The tiers stack: the foundation is the platform, the cellular and hormonal support sit on top of it, and a few items are indication-specific and belong under clinical oversight.

No supplement overcomes a missing foundation. The metabolic, stress, and environmental work is the ground; the foundation supplements are the platform; and the indication-specific items at the top belong only where the indication and a clinician warrant them.

us.fullscript.com/plans/soulflowmechanics-female-fertility - the full stack, in order. We do receive a commission on sales through this link; if you found this useful, it is a way to support the work.

Foundation

Prenatal multivitaminstart 3+ months ahead

A quality prenatal is the platform everything else sits on. Look for activated methyl folate rather than folic acid - the converting enzyme MTHFR is commonly polymorphic and sluggish - iron as bisglycinate chelate rather than ferrous sulfate (non-constipating, better absorbed), iodine, and a full micronutrient and mineral panel. Start at least three months before attempting conception, because folate's window for neural-tube development is the first trimester, often before a pregnancy is confirmed.

This is a case where the human evidence is unambiguous: pre-conception folate lowers the risk of neural-tube defects. It is the one supplement here that every guideline agrees on.

Prenatal Pro · Designs for Health

Omega-3 fatty acids2-4 g daily

Cell-membrane fluidity, inflammatory balance, and fetal neurodevelopment all draw on omega-3s. The fetal neurodevelopment data is robust and well-replicated; the fertility-outcome data is more mixed but generally positive across large meta-analyses. DHA is the primary driver, so favor a product with a meaningful DHA fraction over an undifferentiated EPA/DHA blend.

Designs for Health

Vitamin D3 / K2test, then dose

Vitamin D receptors are present in ovarian tissue, the endometrium, and the placenta, and deficiency is associated with reduced implantation and higher miscarriage risk. Reference range and functional target are different numbers: most labs flag deficiency below 20 ng/mL, while the target commonly used for reproductive function is closer to 50-70 ng/mL, which most people are not reaching on 1,000-2,000 IU/day. Test rather than guess. K2 (as MK-7) is included to direct calcium toward bone rather than soft tissue.

D3/K2 · practice store

Hormonal & metabolic support

Myo-inositol2-4 g daily, divided, with meals

Inositol is an intracellular signaling molecule that governs how insulin drives glucose disposal inside the cell. For reproduction it supports insulin sensitivity at the ovarian level, oocyte quality, and cell-membrane function. The evidence base in PCOS is the strongest - myo-inositol at 2-4 g/day performs comparably to metformin on several metabolic and hormonal parameters in multiple trials, without the gastrointestinal burden, though its effect on live birth specifically remains unproven. In women without PCOS the case is more supportive than proven, resting mainly on oocyte-quality and membrane rationale.

If a formulation uses the 40:1 myo-inositol to D-chiro-inositol ratio, that is the ratio found in healthy follicular fluid, and it is the one to lead with - myo-inositol dominance, not D-chiro. High-dose D-chiro-inositol alone can actually worsen oocyte quality. The PCOS guide works this same molecule in depth, and PCOS (now often termed PMOS) is the most common ovulatory-infertility overlap this guide meets.

40:1 MYO:DCI formulation

Macacycle-phase dependent

Maca is a reproductive adaptogen described as a modulator that helps the HPO axis find its own homeostasis under load rather than a blunt hormonal push. In the follicular phase it may act as a mild follicle-supportive agent at standard doses; across the cycle at lower maintenance doses it is used for stress-axis buffering. The human evidence is early and the mechanism is not fully characterized, so treat the specifics as plausible rather than settled. Even as a supplement it warrants a full clinical discussion before starting - there are phenotypes and situations where timing and dose need to be customized.

Femmenessence MacaHarmony · Symphony Natural Health

Estrogen-metabolism support (DIM / I3C)1 cap daily

A combination approach addressing oocyte quality, estrogen-metabolite balance, and redox status - typically DIM (diindolylmethane) and I3C (indole-3-carbinol) to shift estrogen metabolism toward weaker metabolites, calcium-d-glucarate to support estrogen clearance, plus green tea and antioxidant support. Most relevant for women with estrogen-dominant symptoms - heavy periods, fibroids, endometriosis, fibrocystic breasts. The rationale is mechanistic and the ingredients are individually studied; the combined fertility-outcome evidence is limited, so position it as targeted support rather than a proven fertility treatment.

FemGuard + Balance · Designs for Health

DHEA25-75 mg daily · specific indication only

DHEA is not a general pre-conception supplement. Its use case is narrow: diminished ovarian reserve (low AMH, elevated day-3 FSH) or premature ovarian insufficiency, where it appears to support follicular response and oocyte quality through androgen-receptor signaling in the granulosa cells. The supporting trials are small and the effect is debated. Outside that indication the evidence does not support routine use, and excess androgen activity in women who do not need it carries its own consequences. This one requires clinical oversight and is not for use once pregnant.

practice store · clinician-directed

Cellular & antioxidant support

CoQ10 (ubiquinol)200-600 mg daily

Mitochondrial function inside the oocyte is the energy source for meiosis and early embryonic division, and CoQ10 - specifically the reduced ubiquinol form - is a cofactor in the mitochondrial electron transport chain. Oocyte mitochondrial density and function decline with age, and trials in women over 35 and in poor responders to ovarian stimulation show improvements in oocyte quality and embryo development, though most are small and several sit within IVF cohorts. Start at least sixty to ninety days ahead, matching the oocyte maturation window.

ubiquinol · practice store

N-acetyl cysteine (NAC)600-1200 mg daily

NAC is a glutathione precursor and one of the better-studied antioxidants in this context. Oxidative stress in the follicular environment degrades oocyte quality, and NAC supports the endogenous antioxidant system that manages that load; it also has anti-inflammatory effects and can improve insulin sensitivity, which makes it particularly relevant in PCOS and endometriosis. The PCOS data includes improvements in ovulation and menstrual regularity across several trials, though the quality is moderate and it is not a substitute for the metabolic foundation.

practice store

Melatonin3 mg nightly · pre-conception only

Melatonin is present in follicular fluid at concentrations well above serum, functioning as a local antioxidant within the follicle rather than only a sleep signal, and IVF studies show improved oocyte and embryo quality with supplementation. It carries a firm caveat: melatonin is not established as safe during pregnancy, and this use is pre-conception only. Once pregnancy is confirmed, discontinue - and confirm timing with your provider before starting.

pre-conception only · discontinue when pregnant

Essential amino acidsdaily

Adequate protein is hard to maintain consistently, and the luteal phase in particular draws on circulating amino-acid pools to support endometrial proliferation and ovarian hormone signaling, with connective-tissue demand rising as pregnancy progresses. Starting essential amino-acid support in the pre-conception phase builds the substrate pool before it is needed rather than playing catch-up after implantation. This is substrate insurance more than a targeted fertility agent - the rationale is sound and the risk is low.

EAA formula · practice store

On the male side, the same levers apply. Sperm count, motility, morphology, and DNA fragmentation respond to most of the same inputs - omega-3s, CoQ10, antioxidant capacity, metabolic health, and reduced environmental load. The pre-conception protocol is not gendered at the cellular level. Both partners get the workup and the supplementation. Paternal age carries its own contribution that gets less coverage than maternal age - de novo mutation rates rise with paternal age through a mechanism distinct from oocyte aging - so reproductive timing is not a one-sided conversation.

The panel

What to evaluate

Pre-conception blood work is not optional for anyone who wants to actually know what they are working with. The goal of the panel is not to find problems - it is to establish a baseline honest enough to act on, because most of what shows up is a collection of suboptimal readings that individually feel minor and collectively explain why nothing is working yet. The following is a reasonable baseline for a woman entering active pre-conception planning; a clinician will tailor it to your history.

Six reads on one system: ovarian and HPO, thyroid, metabolic, inflammatory, nutritional, and immune and toxin. This is not an exhaustive list - a mid-luteal progesterone is what confirms ovulation, and the immune and xenobiotic panels are added on history rather than run on everyone.

Cycle & HPO axis

Day-3 FSH LH Estradiol AMH Mid-luteal progesterone

Thyroid & metabolic

TSH Free T3 Free T4 Reverse T3 TPO antibodies Fasting insulin Fasting glucose HbA1c HOMA-IR

Inflammatory, nutritional & immune

hsCRP Homocysteine Vitamin D (25-OH) Ferritin RBC folate Methylmalonic acid Omega-3 index ANA Antiphospholipid Ab Urine xenobiotics

This is not an exhaustive list - it is the core baseline that lets a pre-conception picture be read in context. Mid-luteal progesterone (day 19-21, or 7 days post-ovulation) is the one that confirms ovulation; the TSH target in the pre-conception window is tighter than the standard range, ideally below 2.5 mIU/L. Immune and xenobiotic panels are added on history.

The bottom line

A systems read, before the pregnancy

Pre-conception planning is a systems read on the internal and external conditions that decide whether a pregnancy can initiate, sustain, and develop well. Know your cycle well enough to predict it - and remember that predicting ovulation is not confirming it, which takes a mid-luteal progesterone. Track the hormones if you can. Get the blood work done and read the whole picture rather than waiting for a reference range that was never built for reproductive optimization to flag something.

Address the metabolic foundation, the stress axis, and the environmental load before the pregnancy, not reactively after. The supplement protocol buys coverage across the highest-leverage targets - oocyte quality, hormonal coordination, insulin sensitivity, antioxidant capacity, and the nutritional substrate that conception and gestation will draw on - while the foundation does the heavy lifting underneath it.

This creates the conditions for fertility. It is not an IVF or ovulation-induction program - and the whole picture is exactly what benefits from a clinical eye on the system rather than the standard panel and a wait for something to fall out of range.

Appendix

Progesterone, the luteal phase, and pregnancy oversight

One part of this picture is worth isolating because it is both common and consequential: luteal-phase progesterone. If the follicle was not large enough at rupture, or the corpus luteum cannot sustain output, progesterone runs low and early pregnancy maintenance becomes difficult - which is especially relevant with a history of miscarriage, PCOS, or endometriosis. Tracking the mid-luteal rise, and continuing to check it early in a confirmed pregnancy, can be a meaningful measure. Oral progesterone support is straightforward for a clinician to add when there is a genuine deficit - but it is a clinical decision, made on labs, under supervision, not a self-directed add-on.

Confirm ovulation before reading a luteal deficit. A mid-luteal serum progesterone (about 7 days post-ovulation, often day 19-21) is what establishes that an egg released and the corpus luteum is producing. A single LH strip cannot stand in for this.
Progesterone support is prescriber-directed. Where a deficit is documented, oral or vaginal progesterone can support the luteal phase and early pregnancy - dosing, timing, and duration belong to the clinician managing the pregnancy.
Several supplements stop at conception. Melatonin and DHEA in this guide are pre-conception only; a number of botanicals are not established as safe once trying to conceive or pregnant. Review the whole protocol with your provider before you begin trying, and again once a pregnancy is confirmed.

This appendix is included so you understand what luteal support and pregnancy oversight can look like - not so you run any of it alone. Anything touching an active or attempted pregnancy belongs under a licensed clinician who has your history and your labs.

This guide is educational and is not medical advice, diagnosis, or treatment. It does not replace the judgment of a licensed clinician who knows your history and your labs. Fertility care, hormone therapy, progesterone support, and related interventions are clinical decisions that carry real risks and require monitoring. Several supplements referenced here are pre-conception only and are not for use once trying to conceive or pregnant without provider oversight; supplements can also interact with medications and conditions - review any protocol with your clinician before starting, particularly if you are managing a medical condition, taking prescription medication, trying to conceive, or pregnant. Biomarker panels listed here are illustrative, not exhaustive.